 |
PDBsum entry 2f1b
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Golgi alpha-mannosidase ii complex with (2r,3r,4s,5r)-2-({[(1r)-2- hydroxy-1-phenylethyl]amino}methyl)-5-methylpyrrolidine-3,4-diol
|
|
Structure:
|
 |
Alpha-mannosidase ii. Chain: a. Fragment: catalytic domain. Synonym: mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase, man ii, golgi alpha-mannosidase ii, aman ii. Engineered: yes
|
|
Source:
|
 |
Drosophila melanogaster. Fruit fly. Organism_taxid: 7227. Gene: alpha-man-ii, gmii. Expressed in: drosophila melanogaster. Expression_system_taxid: 7227.
|
|
Resolution:
|
 |
|
1.45Å
|
R-factor:
|
0.173
|
R-free:
|
0.194
|
|
|
Authors:
|
 |
D.A.Kuntz,D.R.Rose
|
Key ref:
|
 |
P.Englebienne
et al.
(2007).
Evaluation of docking programs for predicting binding of Golgi alpha-mannosidase II inhibitors: a comparison with crystallography.
Proteins,
69,
160-176.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
14-Nov-05
|
Release date:
|
05-Dec-06
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q24451
(MAN2_DROME) -
Alpha-mannosidase 2 from Drosophila melanogaster
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1108 a.a.
1014 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.2.1.114
- mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase.
|
|
 |
 |
 |
 |
 |

Pathway:
|
 |
Mannosyl-glycoprotein N-acetylglucosaminyltransferases
|
 |
 |
 |
 |
 |
Reaction:
|
 |
N4-{beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->3)-[alpha- D-Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)- beta-D-GlcNAc}-L-asparaginyl-[protein] + 2 H2O = 2 alpha-D-mannopyranose + an N4-{beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->6)]- beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc}-L-asparaginyl- [protein]
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proteins
69:160-176
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Evaluation of docking programs for predicting binding of Golgi alpha-mannosidase II inhibitors: a comparison with crystallography.
|
|
P.Englebienne,
H.Fiaux,
D.A.Kuntz,
C.R.Corbeil,
S.Gerber-Lemaire,
D.R.Rose,
N.Moitessier.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Golgi alpha-mannosidase II (GMII), a zinc-dependent glycosyl hydrolase, is a
promising target for drug development in anti-tumor therapies. Using X-ray
crystallography, we have determined the structure of Drosophila melanogaster
GMII (dGMII) complexed with three different inhibitors exhibiting IC50's ranging
from 80 to 1000 microM. These structures, along with those of seven other
available dGMII/inhibitor complexes, were then used as a basis for the
evaluation of seven docking programs (GOLD, Glide, FlexX, AutoDock, eHiTS,
LigandFit, and FITTED). We found that small inhibitors could be accurately
docked by most of the software, while docking of larger compounds (i.e., those
with extended aromatic cycles or long aliphatic chains) was more problematic.
Overall, Glide provided the best docking results, with the most accurately
predicted binding around the active site zinc atom. Further evaluation of
Glide's performance revealed its ability to extract active compounds from a
benchmark library of decoys.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Electron density representation of the inhibitors 8,
9 and 10 bound in the active site of dGMII. Maps are simulated
annealing omit maps (F[o]-F[c]) of only the inhibitors contoured
at 3.5 .
For orientation purposes the active site zinc ion is represented
as a magenta ball. This figure was generated with PyMOL.
|
 |
Figure 2.
Figure 2. (a) Interaction of 8 with residues in the active site
of dGMII. Interactions closer than 3.2 Å are indicated
with cyan dotted lines; interactions with the zinc ion are
indicated in magenta. Water molecules appear as orange balls.
Distances are presented in Table III. This figure was generated
with PyMOL.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from John Wiley & Sons, Inc.:
Proteins
(2007,
69,
160-176)
copyright 2007.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
D.Plewczynski,
M.Laźniewski,
R.Augustyniak,
and
K.Ginalski
(2011).
Can we trust docking results? Evaluation of seven commonly used programs on PDBbind database.
|
| |
J Comput Chem,
32,
742-755.
|
 |
|
|
|
|
 |
D.A.Kuntz,
W.Zhong,
J.Guo,
D.R.Rose,
and
G.J.Boons
(2009).
The Molecular Basis of Inhibition of Golgi alpha-Mannosidase II by Mannostatin A.
|
| |
Chembiochem,
10,
268-277.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Venkatesan,
D.A.Kuntz,
and
D.R.Rose
(2009).
Human lysosomal alpha-mannosidases exhibit different inhibition and metal binding properties.
|
| |
Protein Sci,
18,
2242-2251.
|
 |
|
|
|
|
 |
N.Moitessier,
P.Englebienne,
D.Lee,
J.Lawandi,
and
C.R.Corbeil
(2008).
Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go.
|
| |
Br J Pharmacol,
153,
S7-26.
|
 |
|
|
|
|
 |
L.Xie,
J.Wang,
and
P.E.Bourne
(2007).
In silico elucidation of the molecular mechanism defining the adverse effect of selective estrogen receptor modulators.
|
| |
PLoS Comput Biol,
3,
e217.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |